# Solara Active Pharma Sciences Limited - Inspection Records

Source: https://www.keypedia.com/companies/solara-active-pharma-sciences-limited/8f3f8236-f49d-43e3-84af-2cb404fb8264

> Inspection records and compliance data for Solara Active Pharma Sciences Limited in Tamil Nadu, None. Access full analysis and detailed observations.

---

## Details

- Name: Solara Active Pharma Sciences Limited
- FEI Number: 3003585876
- City: Tamil Nadu
- State: None
- Country Name: India
- Address Line 1: A - 1/B Sipcot Industrial Complex
- Address Line 2: Kudikkadu
- Zip Code: None
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING

## Related Documents

- [FDA Inspection 1217304 - Solara Active Pharma Sciences Limited - 2023-08-04](https://www.keypedia.com/records/fda_inspections/solara-active-pharma-sciences-limited/294fb3d3-0209-47d3-82c5-7a7f63121e5a) — classification: No Action Indicated (NAI), source: FDA, date: August 4, 2023
- [483 - Solara Active Pharma Sciences Limited - 2020-03-07](https://www.keypedia.com/records/483/solara-active-pharma-sciences-limited/7d70b556-391f-40c4-9950-7b1d3edd1782) — source: FDA, date: March 7, 2020
- [483 - Solara Active Pharma Sciences Limited - 2020-03-07](https://www.keypedia.com/records/483/solara-active-pharma-sciences-limited/bfad62bb-d490-4053-9c63-d2a455c186ac) — source: FDA, date: March 7, 2020
- [FDA Inspection 1123376 - Solara Active Pharma Sciences Limited - 2020-03-07](https://www.keypedia.com/records/fda_inspections/solara-active-pharma-sciences-limited/b06c155c-f9f4-4d15-9b1c-575f05bc112a) — classification: Official Action Indicated (OAI), source: FDA, date: March 7, 2020
- [EIR - Solara Active Pharma Sciences Limited - 2019-07-05](https://www.keypedia.com/records/eir/solara-active-pharma-sciences-limited/c4b2ed11-279a-448d-a8e4-a73b060666c2) — source: FDA, date: July 5, 2019
- [FDA Inspection 1012921 - Solara Active Pharma Sciences Limited - 2017-04-21](https://www.keypedia.com/records/fda_inspections/solara-active-pharma-sciences-limited/ade0ea5b-47b0-4547-b923-b16b4dc09046) — classification: No Action Indicated (NAI), source: FDA, date: April 21, 2017
- [EIR - Solara Active Pharma Sciences Limited - 2017-04-17](https://www.keypedia.com/records/eir/solara-active-pharma-sciences-limited/b52dee6b-7a2a-4bd6-be54-cb3191b49960) — source: FDA, date: April 17, 2017
- [FDA Inspection 888196 - Solara Active Pharma Sciences Limited - 2014-06-13](https://www.keypedia.com/records/fda_inspections/solara-active-pharma-sciences-limited/23ba0e2e-f2f9-4249-a5dd-cf49ce267266) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 13, 2014
- [FDA Inspection 719450 - Solara Active Pharma Sciences Limited - 2011-04-08](https://www.keypedia.com/records/fda_inspections/solara-active-pharma-sciences-limited/2df53902-a0e4-4271-8191-abb08e413d4e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 8, 2011
- [FDA Inspection 704735 - Solara Active Pharma Sciences Limited - 2010-11-16](https://www.keypedia.com/records/fda_inspections/solara-active-pharma-sciences-limited/6455395f-3d38-4e62-8676-2023005caf58) — classification: No Action Indicated (NAI), source: FDA, date: November 16, 2010

## Related Companies

- [Lonza Biologics, Inc.](https://www.keypedia.com/companies/lonza-biologics-inc/f9882ce5-d92a-4c88-916e-8f4e6d1f2aff)
- [Biogen MA Inc.](https://www.keypedia.com/companies/biogen-ma-inc/85b778d2-1e69-485d-9e93-05c656646fa2)
- [GlaxoSmithKline dba Human Genome Sciences Inc](https://www.keypedia.com/companies/glaxosmithkline-dba-human-genome-sciences-inc/c3dd2e54-125d-4d56-b0dc-18cb333074cc)
- [Bachem Americas, Inc.](https://www.keypedia.com/companies/bachem-americas-inc/f0157d2d-6b0c-4b13-afd4-551c2ab94aad)
- [AGILENT TECHNOLOGIES INC./US](https://www.keypedia.com/companies/agilent-technologies-incus/f39880d4-233e-44bc-9a9e-56d1f9b48065)
- [Spark Therapeutics, Inc.](https://www.keypedia.com/companies/spark-therapeutics-inc/a5518493-a117-41d3-862d-96d5a5d3b6dd)
- [Organo Sintesis, S.A. De C.V.](https://www.keypedia.com/companies/organo-sintesis-sa-de-cv/0d8f4d8d-0fbd-4c4a-8362-439c74e4f37d)
- [MSN Laboratories Private Limited, Unit-II](https://www.keypedia.com/companies/msn-laboratories-private-limited-unit-ii/539d7af5-94e6-4abe-b01b-fa911be84d2a)
- [UQUIFA Mexico, S.A. de C.V.](https://www.keypedia.com/companies/uquifa-mexico-sa-de-cv/8523a240-e52a-495e-a781-e12c6412dc69)
- [Lonza AG](https://www.keypedia.com/companies/lonza-ag/7084f7e6-ce36-429f-942a-28e759416e70)

## Related Officers

- [Investigator](https://www.keypedia.com/people/kham-phommachanh/cc7e728e-d2a1-469d-be3a-4f5fdd43b2dc)
- [other](https://www.keypedia.com/people/karen-g-sego/7742d0a3-dfa4-4350-aa58-1b5568a417a8)
- [Consumer Safety Officer](https://www.keypedia.com/people/nadeem-i-chaudhry/7d867939-2dc6-4503-b9b9-6f26b16c347e)
- [Miguel A. Martinez](https://www.keypedia.com/people/miguel-a-martinez/62e722b2-30bd-4671-9db9-8f089093e5a5)
- [Pharmaceuticals ](https://www.keypedia.com/people/zedong-dong/8ef8185c-523a-4b16-ab37-863746d71787)